Mass General Brigham to Invest $100 Million in Telehealth and Digital Tools.
The five-year project aims to support consumer-centered care and patient engagement technology use.
PatientEngagementHIT.com
"Project...
New Preferred Stock IPOs, October 2019
Article ArchivePreferred Stock Investing Website
Summary
Thirteen new preferred stocks were introduced during October offering...
Is True Nature (TNTY) $0.04, Nearing a Breakout?
After a Tough Year, a Series of Development Releases Appears to Have Halted True Natures Downtrend and Move to a Possible...
True Nature’s (TNTY) CEO Larry Diamond on Wall Street Analyzer.
Larry Diamond Reveals Some of True Nature's Goals and Ambitions to Incubate Medical Related Startups to Benefit All Shareholders.
True Nature | Mitesco (TNTY), Perking Up.
Is it too early to nick-name True Nature's Medtech incubator Mitesco the "Mighty Mitesco?" Of course it's too early - but it...
Stand Down IV: Remember This? Alta Vista Cancels IPO. David Wetherell Takes a $2...
We are going through some of our very old 'incubator files' back from when we ran the Incubator Stock Review, a spinoff...
IDEALAB. First Mover, Last Survivor.
CLICK TO READ
Founded by Bill Gross in 1996, Idealab has created more than 150 companies, which fueled...
True Nature (TNTY) Mitesco Set to Launch Mitesco PLC Incubator — Aligns With Matheson...
Hires Legal Powerhouse Matheson as Counsel and Advisor on its European Acquisitions Efforts.
Established...
What We’re Watching.
“Biotech, Beverages and Bears - Oh My!”
— Daniel K. McMahon
True Nature (TNTY) Readies Launch of Mitesco: “The Medtech Incubator”
ATLANTA, GA, Nov. 05, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- True Nature Holding, Inc. (OTCQB: TNTY, “the Company”) today announced that...
Latest article
Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.
Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!
Citius Pharmaceuticals (CTXR) Prospectus, Powerpoint & Fact Sheet.
CRANFORD, N.J., April 26, 2024 /PRNewswire/ -- Citius Pharmaceuticals Inc. (Nasdaq: CTXR) ("Citius" or the "Company"), a late-stage biopharmaceutical company dedicated to the development and commercialization...
GeoVax (GOVX) Launches Vaccine Manufacturing System.
GeoVax Achieves Milestone in Transition to Commercially Validated Manufacturing System
Manufacturing Process for Phase 3 and Commercial Production...
